Overactive Bladder

Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). June 23, 2019

Outcomes of Sacral Nerve Stimulation for Treatment of Refractory Overactive Bladder Among Octogenarians. June 23, 2019

A PROSPECTIVE STUDY TO EVALUATE EFFICACY USING THE NURO™ PERCUTANEOUS TIBIAL NEUROMODULATION SYSTEM IN DRUG-NAÏVE PATIENTS WITH OVERACTIVE BLADDER SYNDROME (OAB). June 16, 2019

Cure of Underactive and Overactive Bladder Symptoms in Women by 1,671 Apical Sling Operations Gives Fresh Insights into Pathogenesis and Need for Definition Change. June 16, 2019

Exploring biomarkers in the overactive bladder: Alterations in miRNA levels of a panel of genes in patients with OAB. June 9, 2019

Efficacy and tolerability of mirabegron in female patients with overactive bladder symptoms after surgical treatment for stress urinary incontinence. June 9, 2019

Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial. June 2, 2019

A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. June 2, 2019

Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy. May 26, 2019

Treatment Satisfaction with Flexible-dose Fesoterodine in Patients with Overactive Bladder who were Dissatisfied with Previous Anticholinergic Therapy: A Multicenter Single-Arm Clinical Study. May 26, 2019

New technologies in the management of overactive bladder: current research and future prospects. May 19, 2019

Combination Pharmacotherapy for Treatment of Overactive Bladder (OAB). May 19, 2019

Relative Risk of Adverse Events and Treatment Discontinuations Between Older and Non-Older Adults Treated with Antimuscarinics for Overactive Bladder: A Systematic Review and Meta-Analysis. May 12, 2019

Are We missing out the role of oxytocin in overactive bladder syndrome? May 12, 2019

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. May 5, 2019

How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinA. May 5, 2019

Pathophysiology of refractory overactive bladder. April 28, 2019

Comparison of body composition and overactive bladder symptoms in overweight female university students. April 28, 2019

Urodynamic and Bladder Diary Factors Predict Overactive Bladder-wet in Women: A Comparison With Overactive Bladder-dry. April 14, 2019

Antimuscarinic drug therapy for overactive bladder syndrome in the elderly - are the concerns justified? April 14, 2019

Page 1 of 80

Pelvic Health Weekly Newsletter